CCL5 and esophageal squamous cell carcinoma: Our in vivo experiments also indicated that the therapy effect was strengthened by recombinant CCL5 protein in conjunction with immunochemotherapy, potentially providing a safe and effective treatment regimen with translational potential for the effective therapy of ESCC.